Celyad Oncology SA CYAD
EURONEXT · Belgium · Health Technology
€0.2200-0.00 (-0.45%)
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
MONT-SAINT-GUIBERT, Belgium, September 23, 2026--Regulatory News: Celyad Oncology (Euronext: CYAD) ("Celyad" or the "Company"), today announced its financial results for the first half year 2026 ended June 30, 2026.
MONT-SAINT-GUIBERT, Belgium, July 14, 2026--Celyad Oncology Announces €500,000 Private Placement
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.